meldepliktige handler fra primærinnsidere

← Alle transaksjoner

EXACT THERAPEUTICS AS - MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER

EXACT Therapeutics AS (EXTX) · publisert 2021-12-05 14:33 · vis på NewsWeb

Transaksjoner

PersonRolleTypeVolumPrisDatoISINHandelsplassTolket via
Andrew J. Healy The notification concerns a Primary insider: CSO, Andrew J. Healydisposal1 24916,0196 NOK2021-12-02MERK – Oslo Børsrules
Andrew J. Healy The notification concerns a Primary insider: CSO, Andrew J. Healydisposal88617,1806 NOK2021-12-03MERK – Oslo Børsrules
PAACS Invest AS nærståendeThe notification concerns a close associate of a a Primary insider: Chairperson, Masha Strømmedisposal2 49816,0196 NOK2021-12-02MERK – Oslo Børsrules
PAACS Invest AS nærståendeThe notification concerns a close associate of a a Primary insider: Chairperson, Masha Strømmedisposal1 77217,1806 NOK2021-12-03MERK – Oslo Børsrules
Kvåle AS nærståendeThe notification concerns a close associate of a a Primary insider: COO, Svein Kvåledisposal2 49816,0196 NOK2021-12-02MERK – Oslo Børsrules
Kvåle AS nærståendeThe notification concerns a close associate of a a Primary insider: COO, Svein Kvåledisposal1 77217,1806 NOK2021-12-03MERK – Oslo Børsrules

Vedlegg

Meldingstekst

Oslo, 5 December 2021 Masha Strømme, chair of EXACT Therapeutics AS has on 2 December 2021 acquired 2 498 shares at an average price of NOK 16.0196 and on 3 December 2021 acquired 1 772 shares at an average price of NOK 17.1806, in EXACT Therapeutics AS. The shares were acquired through PAACS Invest AS, Dr. Strømme’s investment company. Following the transaction, Dr. Strømme controls 2 689 009 shares in EXACT Therapeutics AS. EXACT THERAPEUTICS AS - MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER Oslo, 5 December 2021 Svein Kvåle, COO and Co-Founder of EXACT Therapeutics AS has on 2 December 2021 acquired 2 498 shares at an average price of NOK 16.0196 and on 3 December 2021 acquired 1 772 shares at an average price of NOK 17.1806, in EXACT Therapeutics AS. The shares were acquired through Kvåle AS, a company controlled by Dr. Kvåle. Following the transaction, Dr. Kvåle controls 3 021 770 shares in EXACT Therapeutics AS. EXACT THERAPEUTICS AS - MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER Oslo, 5 December 2021 Andrew J. Healy, CSO and Co-Founder of EXACT Therapeutics AS has on 2 December 2021 acquired 1 249 shares at an average price of NOK 16.0196 and on 3 December 2021 acquired 886 shares at an average price of NOK 17.1806, in EXACT Therapeutics AS. Following the transaction, Dr. Healy controls 2 205 385 shares in EXACT Therapeutics AS.